Program of IANR VI & 10th GCNN Annual Conference

Address of the Chairman of the Conference

Prof. Dafin F. Muresanu

Address of the President of IANR

Prof. Ziad M. Al Zoubi

Address of the President of GCNN

Prof. Hari S. Sharma

Address of Romanian Ministry of Health

Session I: (09:00-12:05) General Neurorestoratology

09:00-09:20

The pathway hypothesis (Geoffrey Raisman, UK)

09:20-09:40

Evidence and questioned: Patients with complete chronic SCI have been able to get clinical neurorestoration (Hongyun Huang, China)

09:40-10:00

Development of international ethical standards for stem cell-based therapy (Ziad Al-Zoubi, Jordan)

10:00-10:15

Discussion

10:15-1035

Coffee Break

10:35-10:55

How to bridge the gap between basic and clinical concepts in CNS protection and recovery?(Dafin F. Muresanu, Romania)

10:55-11:15

High performance neuroprosthetic control by an individual with tetraplegia (Andrew Schwartz, USA)

11:15-11:35

CNS injury and repair. novel therapeutic strategies and nanodrug delivery (Hari S Sharma, Sweden)

11:35-11:55

Intranasal delivery of cells: a newcomer in cell-based therapy of brain disorders (Lusine Danielyan, Germany)

11:55-12:05

Discussion

12:05-13:30

Lunch at Hotel

Session II: (13:30-15:50) Neuromodulation and Neuroprostheses

13:30 -13:50

The processing capabilities of the human lumbar cord, "spinal brain" and restoration of movement (Milan Dimitrijevic, USA)

13:50-14:10

Walk by people with lower limbs paralysis using intelligent robot (Xijing He, China)

14:10-14:30

Long-term  sensory stimulation therapy improves hand function and restores  cortical responsiveness in patients with chronic cerebral lesions (Hubert R Dinse, Germany)

14:30-14:50

Use  of laser and light on the regulation of growth factors and inflammatory  mediators involved in oligodendrocyte maturation and function and  myelin repair (Anu Makela, Finland)

14:50-15:10

What is pain?(with special reference to neuropathic pain (Dajue Wang, UK)

15:10-15:30

Discussion

15:30-15:50

Coffee Break

Session III: (15:50-18:10)  Tissue Engineering and Bioengineering

15:50-16:10

The role of microRNAs in mediating brain plasticity after stroke, neural injury and neurodegenerative disease (Michael Chopp, USA)

16:10-16:30

Epigenetics control in neurodegeneration (Harry Steinbusch, Holland)

16:30-16:50

Proteome-modified  individualized anticancer cell systems in neurology: from postgenome  technologies of proteome mapping and protein profiling to modeling of  gene expression transcriptome profiles and peptide engineering of stem  and progenitor cells (Andrey S. Bryukhovetskiy, Russia)

16:50-17:10

The Experimental Study on Restoration of Blood Supply in Injured Brain by Tissue Engineering (Qunyuan Xu,China)

17:10:17:30

Tissue Engineering - Where Do We Stand? (Raymund Horch)

17:30-17:50

Improving in vivo osteogenic differentiation of mesenchymal stem cells ( Mihaela Baciut)

17:50-18:10

Discussion

18:00-20:00

Dinner

Session IV: (13:30-16:40) Neurorestorative Pharmacotherapy

13:30 -13:50

Comparative  study of neurological and functional outcomes of Granulocyte-Colony  Stimulating Factor administration in motor complete vs. motor incomplete  post-rehabilitated, chronic spinal cord injuries (Hooshang Saberi, Iran)

13:50-14:10

Palmitoylethanolamide, an anandamide congener, has wide-acting neuroprotective actions (Stephen Skaper, Italy)

14:10-14:30

Neural Stem Cell-Derived Models for Studying Anesthesia-Induced Neurotoxicity and Preventative Strategies (William Slikker , USA)

14:30-14:45

Discussion

14:45-15:05

Cerebrolysin attenuates negative effect of high temperature on longevity in Drosophila model  (Gregory Oxenkrug , USA)

15:05-15:25

Zonisamide protects motor neuron death against glutamate mediated neurotoxicity (Yasuo Iwasaki , Japan)

15:25-15:45

Neurorestoration in Alzhimer’s disease and depression: is BDNF the link molecule? (Anton Alvarez)

15:45-16:05

Do meninges and choroid plexus play a role in neuroregeneration? (Bogdan Popescu)

16:05-16:20

Discussion

16:20-16:40

Coffee Break

Session V: (16:40-18:10) Hereditary Neurorestoratology

16:40-17:00

Striatal allografts in Huntington’s disease patients: impact of diminished astrocytes and vascularization on graft viability (Francesca Cicchetti,Canada)

17:00:17:20

Preliminary report of umbilical cord stromal cell therapy for patients with muscular dystrophy (Haitao Xi, China)

17:20-17:40

Muscle-precursor cell transplantation in Duchenne muscular dystrophy (Danial Skuk, Canada)

17:40-18:00

Mesenchymal stem cells in the treatment of multiple sclerosis (Ovidiu Bajenaru)

18:00-18:10

Discussion

18:00-20:00

Dinner

Session VI: (08:30-12:00) Traumatic Neurorestoratology (SCI)

08:30-08:50

Consideration on neuroprotection, neurorecovery, and prognosis after blast SCI (Klaus von Wild,Germany)

08:50-09:10

Transplantation  of Purified Autologous CD34+ and CD133+ Stem Cells for Patients with  Chronic Spinal Cord Injuries: Evaluation of Safety and Long-term Follow  up Results (Adeeb Al-Zoubi, Jordan)

09:10-09:30

Effect of OECs transplantation on sympathetic skin response and nerve function of patients with late spinal cord injury (Zuncheng Zheng, China)

09:30-09:50

ProBDNF Inhibits Proliferation and Migration of Oligodendrocyte Precursor Cells after Spinal Cord Injury (Shiqing Feng, China)

09:50-10:10

Discussion

10:10-10:30

Coffee Break

10:30-10:50

Reflections on the (STASCIS) study (Wagih S El Masri, UK)

10:50-11:10

Scientific Rationale for using Locomotor Training in Spinal Cord Injuries (Ali Otom, Jordan)

11:10-11:30

Comparison between leukopherisis and bone marrow in stem cell therapy for spinal cord injury (Emad Jafar, Jordan)

11:30-11:45

Evaluation of Social support among Iranian patients with Spinal Cord Injury (Zahra Khazaeipour,Iran)

11:45-12:00

Discussion

12:00-13:30

Lunch at hotel

Session VII: (13:30-16:00)  Traumatic Neurorestoratology (SCI)

13:30-13:50

Complete  paraplegia patient in chronic spinal cord injury with involuntary  muscle spasm expressed motor evoked potential after olfactory mucosa  autograft (Koichi Iwatsuki,Japan)

13:50-14:10

Animal results in the use of a scaffold to solve the problem of spinal cord injury with anatomic discontinuity (Gustavo Moviglia, Agentina)

14:10-14:25

Effect of diet on prevention and treatment of metabolic syndrome in patients with chronic spinal cord injury

(Hadis Sabour,Iran)

14:25-14:35

Discussion

14:35-14:55

A  perspective randomized double blinded clinical trial of olfactory  ensheathing cell combined with Schwann cell for the chronic complete  spinal cord injury (Lin Chen, China)

14:55-15:15

Co-transplantation  of olfactory ensheathing cells and Schwann cells combining treadmill  training promote functional recovery from rat with spinal cord contused (Tiansheng Sun, China)

15:15-15:30

Bone loss in chronic Spinal Cord Injury (Abbas Noroozi Javidan , Iran)

15:30-15:40

Discussion

15:40-16:00

Coffee Break

Session VIII: (16:00-18:00) IANR Youth Forum

A Systematic Review of Reported Neuroprotective Treatments for Spinal Cord Injuries (Nazi Derakhshan Rad,Iran)

A preliminary work report in vivo: efficacy studies on the treatment of iPS for spinal cord injury

(Xianhu Zhou,China)

Prospective  comparison of life quality of spinal cord injury females seeking  cellular treatments between war veterans and non-battle related injuries (Manijeh Yazdanshenas Ghazvin,Iran)

Down-regulation of PTPσ receptor promotes axon regeneration after spinal crod injury

(Hengxing Zhou,China)

Lentivirus-siNgR promotes axonal regeneration and functional recovery in spinal cord contusion rats (Chao Zhang,China)

Intravenous  administration of Functionalized Magnetic Iron Oxide Nanoparticles does  not induce CNS injury in the rat. Influence of spinal cord trauma and  cerebrolysin treatment (Preeti Menon,Sweden)

The  experimental study of transplantation of human bone marrow-derived  mesenchymal stem cell through different routes to treat cerebral  ischemia in rats (Shiwei Du,China)

Session IX: (09:00-12:00) Cardiac Telocytes

(S. Kostin, Germany)

(DQ. Cai, China)

(G. Bussolati, Italy)

(E. Wang, China)

(N. Kawaguchi, Japan)

(Mihaela Gherghiceanu, Romania)

Session X: (14:00-17:00) Telocytes In Uro-genital Tract

(M. Taggart, UK)

(XJ. Yang, China)

(T. Gevaert, Belgium)

(J. Gillespie, UK)

(K. Hatta, Canada)

(Sofia Teresa Rosenbaum, Denmark)

(D. Cretoiu, Romania)

         Session XI: (08:30-10:25)   Traumatic Neurorestoratology (SCI)

08:30-08:50

Umbilical Cord Blood and Lithium Treatment of Chronic Spinal Cord injury (Wise Young, USA)

08:50-09:10

Cauda equina nerve root lysis using hydraulic expansion method (Shaocheng Zhang, China)

09:10-09:30

Imaging of chronic spinal cord injury (Mohammad Jamous, Jordan)

09:30-09:45

Social networking for spinal injury health promotion (Amirkhani Mohammadamir, Iran)

09:45-10:05

Discussion

10:05-10:25

Coffee Break

         Session XII: (10:25-12:00)   Traumatic Neurorestoratology (CNS)

10:25-10:45

Peripheral nerve grafting and considerations on brain plasticity (Giorgio Brunelli,Italy)

10:45-11:05

New Aspects of Pharmacological Neuromodulation and Spinal Cord Plasticity in Fokal CNS Lesions in Rats (Tobias von Wild, Germany)

11:05-11:25

Nanomedicine in Neuroscience: the potential of targeted nanoparticles in neurodegenerative disorders (Giovanni Tosi, Italy)

11:25-11:45

Transplantation of adipose tissue stem cells for the treatment of traumatic brain injury (Spyros Petrakis)

11:45-12:00

Discussion

         Session XIII: (13:30-16:10)   Pediatric Neurorestoratology

13:30-13:50

The role of adult stem cell therapy in autism and other neurodevelopmental disorders (Alok Sharma, India)

13:50-14:10

Efficacy of fetal stem cell transplantation in autism spectrum disorders: a pilot study (Dario Siniscalco, Italy)

14:10-14:30

Treatment of Autism with adipose tissue derived mesenchymal stem cells (Xenia Geronikola Trapalis)

14:30-14:45

Discussion

14:45-15:05

Cell therapy and challenges of refractory neonatal encephalopathy (Zuo Luan, China)

15:05-15:25

Evaluation Effect of Acupuncture and Neural stem cells and their combination therapy on Newborn Rats with Cerebral palsy (Yanchao Qi, China)

15:25-15:40

Brain Nervous development and Neurorestoratology of Children with Cerebral Palsy by Acupuncture (Zhenhuan Liu,China)

15:40-15:50

Discussion

15:50-16:10

Coffee Break

Session XIV: (16:10-18:00) Basic Research of Neurorestoratology＆Others

16:10-16:30

Sonic  hedgehog released from scratch-injured astrocytes is a key signal  necessary but not sufficient for the astrocyte de-differentiation (Siwei You, China)

16:30-16:50

Mechanisms research of neuroregeneration and repairment  after spinal cord injury (Peng Liang, China)

16:50-17:10

Different  pathways involved in the immunomodulate role of human placenta-derived  mesenchymal stem cell mediated by PD-L1 and FasL（, Qun Xue,China）

17:10-17:30

Why have telocytes? (LM Popescu)

17:30-17:50

Discussion

Session XV: (09:00-12:00) Varia

(XD. Wang, China)

(Giuliana Vannucchi, Italy)

(G. Radenkovic, Serbia)

(M. Manetti, Italy)

(Donna Briggs Bødtkjer, Denmark)

(Florina Bojin, Romania)

Session XVI: (13:30-17:30) Geriatric Neurorestoratology

13:30-13:50

Neuroimaging and Transplantation in Parkinson’s disease (Marios Politis,UK)

13:50-14:10

What are the challenges with taking a stem cell therapy to the clinic for treating Parkinson’s Disease? (Roger A. Barker, UK)

14:10-14:30

Depletion of agrin, a BBB basement membrane, in advanced Alzheimer’s disease (Conrad Johanson, USA)

14:30-14:50

Administration of adipose derived mesenchymal stem cells in three patients with Alzheimer’s Disease (George Koliakos)

14:50-15:10

Discussion

15:10-15:30

Coffee Break

15:30-15:50

Intra-arterial BM-MNCs transplantation in subacute ischemic stroke (Francisco Moniche,Spain)

15:50-16:10

Clinical progress and lessons learned of cell therapy trials in patients with acute ischemic stroke (Sean Savitz,USA)

16:10-16:30

The primary study of stem cells transplantation in stroke patients (Tongchao Geng ＆ Liyan Qiao,China)

16:30-16:50

Cell-based therapy in the treatment of stroke: challenges and possibilities (Elena Rem Chernykh, Russia)

16:50-17:10

Transplantation  of human bone marrow-derived mesenchymal stem cell through artery route  promotes angiogenesis and recovery of neurological function after  cerebral ischemia in rats (Gengsheng Mao,China)

17:10-17:30

Discussion